Abstract

The original version of this Article contained an error in the spelling of the author James C. Mulloy, which was incorrectly given as James Mulloy. This has now been corrected in both the PDF and HTML versions of the Article.

Details

Title
Author Correction: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
Author
Jiang, Xi 1 ; Hu, Chao 2 ; Ferchen, Kyle 3 ; Nie, Ji 4 ; Cui, Xiaolong 4 ; Chih-Hong, Chen 5 ; Cheng, Liting 6 ; Zuo, Zhixiang 7 ; Seibel, William 8 ; He, Chunjiang 9 ; Tang, Yixuan 6 ; Skibbe, Jennifer R 3 ; Wunderlich, Mark 10 ; Reinhold, William C 11 ; Dong, Lei 12 ; Shen, Chao 12 ; Arnovitz, Stephen 13 ; Bryan, Ulrich 13 ; Lu, Jiuwei 3 ; Weng, Hengyou 1 ; Su, Rui 12 ; Huang, Huilin 12 ; Wang, Yungui 2 ; Li, Chenying 14 ; Qin, Xi 12 ; Mulloy, James C 10 ; Zheng, Yi 10 ; Diao, Jiajie 3   VIAFID ORCID Logo  ; Jin, Jie 15 ; Li, Chong 6 ; Liu, Paul P 16 ; He, Chuan 4 ; Chen, Yuan 5 ; Chen, Jianjun 1 

 Department of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, USA 
 Department of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA; Department of Hematology, The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China 
 Department of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA 
 Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, Howard Hughes Medical Institute, University of Chicago, Chicago, IL, USA 
 Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA, USA 
 Key Laboratory of Luminescence and Real-time Analytical Chemistry (Ministry of Education), College of Pharmaceutical Sciences, Southwest University, Chongqing, China 
 Department of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China 
 Division of Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA 
 School of Basic Medical Sciences, Wuhan University, Wuhan, China 
10  Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA 
11  Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA 
12  Department of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, USA 
13  Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA 
14  Department of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, USA; Department of Hematology, The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China 
15  Department of Hematology, The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China 
16  Genetics and Molecular Biology Branch, National Human Genome Research Institute, NIH, Bethesda, MD, USA 
Pages
1-1
Publication year
2018
Publication date
Feb 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2000012648
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.